{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:39:31Z","timestamp":1793723971508,"version":"4.6.1"},"reference-count":230,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41569-026-01276-w","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:19:13Z","timestamp":1774531153000},"page":"801-815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Global epidemiology of myocarditis: disparities in age, sex and geography"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0203-2498","authenticated-orcid":false,"given":"Karin","family":"Klingel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tsch\u00f6pe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0387-5326","authenticated-orcid":false,"given":"George A.","family":"Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany N.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-5507","authenticated-orcid":false,"given":"Amy R.","family":"Kontorovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie T.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1676-5257","authenticated-orcid":false,"given":"Enrico","family":"Ammirati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"1276_CR1","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jama.2023.3371","volume":"329","author":"E Ammirati","year":"2023","unstructured":"Ammirati, E. & Moslehi, J. J. Diagnosis and treatment of acute myocarditis: a review. JAMA 329, 1098\u20131113 (2023).","journal-title":"JAMA"},{"key":"1276_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1251780","volume":"11","author":"N Musigk","year":"2024","unstructured":"Musigk, N. et al. The inflammatory spectrum of cardiomyopathies. Front. Cardiovasc. Med. 11, 1251780 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"1276_CR3","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","volume":"46","author":"J Schulz-Menger","year":"2025","unstructured":"Schulz-Menger, J. et al. 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur. Heart J. 46, 3952\u20134041 (2025).","journal-title":"Eur. Heart J."},{"key":"1276_CR4","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah, G. A. et al. Global burden of cardiovascular diseases and risks, 1990\u20132022. J. Am. Coll. Cardiol. 82, 2350\u20132473 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati, E. et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ. Heart Fail. 13, e007405 (2020).","journal-title":"Circ. Heart Fail."},{"key":"1276_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","volume":"85","author":"MH Drazner","year":"2024","unstructured":"Drazner, M. H. et al. 2024 ACC Expert Consensus Decision Pathway on strategies and criteria for the diagnosis and management of myocarditis: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 85, 391\u2013431 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR7","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"AL Caforio","year":"2013","unstructured":"Caforio, A. L. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 34, 2636\u20132648 (2013).","journal-title":"Eur. Heart J."},{"key":"1276_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2022.107492","volume":"62","author":"ZA Lu","year":"2022","unstructured":"Lu, Z. A. et al. Myocarditis and endomyocardial biopsy: achieving consensus diagnosis on hundred cases. Cardiovasc. Pathol. 62, 107492 (2022).","journal-title":"Cardiovasc. Pathol."},{"key":"1276_CR9","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ejhf.2190","volume":"23","author":"PM Seferovic","year":"2021","unstructured":"Seferovic, P. M. et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society position statement on endomyocardial biopsy. Eur. J. Heart Fail. 23, 854\u2013871 (2021).","journal-title":"Eur. J. Heart Fail."},{"key":"1276_CR10","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/eurheartj\/ehae169","volume":"45","author":"ALP Caforio","year":"2024","unstructured":"Caforio, A. L. P. et al. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-term Registry. Eur. Heart J. 45, 2548\u20132569 (2024).","journal-title":"Eur. Heart J."},{"key":"1276_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","volume":"18","author":"C Tsch\u00f6pe","year":"2021","unstructured":"Tsch\u00f6pe, C. et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat. Rev. Cardiol. 18, 169\u2013193 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"1276_CR12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.058457","volume":"146","author":"AS Lota","year":"2022","unstructured":"Lota, A. S. et al. Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy. Circulation 146, 1123\u20131134 (2022).","journal-title":"Circulation"},{"key":"1276_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jacbts.2021.06.001","volume":"6","author":"AR Kontorovich","year":"2021","unstructured":"Kontorovich, A. R. et al. Myopathic cardiac genotypes increase risk for myocarditis. JACC Basic Transl. Sci. 6, 584\u2013592 (2021).","journal-title":"JACC Basic Transl. Sci."},{"key":"1276_CR14","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira, V. M. et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J. Am. Coll. Cardiol. 72, 3158\u20133176 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.118.035319","volume":"138","author":"E Ammirati","year":"2018","unstructured":"Ammirati, E. et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: Multicenter Lombardy Registry. Circulation 138, 1088\u20131099 (2018).","journal-title":"Circulation"},{"key":"1276_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005306","volume":"6","author":"A Arola","year":"2017","unstructured":"Arola, A. et al. Occurrence and features of childhood myocarditis: a nationwide study in Finland. J. Am. Heart Assoc. 6, e005306 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"1276_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ejim.2023.06.002","volume":"115","author":"E Conte","year":"2023","unstructured":"Conte, E., Leoni, O., Ammirati, E., Imazio, M. & Brucato, A. Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children. Eur. J. Intern. Med. 115, 140\u2013142 (2023).","journal-title":"Eur. J. Intern. Med."},{"key":"1276_CR18","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1093\/eurheartj\/ehad339","volume":"44","author":"JY Cho","year":"2023","unstructured":"Cho, J. Y. et al. COVID-19 vaccination-related myocarditis: a Korean nationwide study. Eur. Heart J. 44, 2234\u20132243 (2023).","journal-title":"Eur. Heart J."},{"key":"1276_CR19","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 76, 2982\u20133021 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR20","unstructured":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990\u20132023. J. Am. Coll. Cardiol. 86, 2167\u20132243 (2025)."},{"key":"1276_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27631-8","volume":"13","author":"LS Nguyen","year":"2022","unstructured":"Nguyen, L. S. et al. Systematic analysis of drug-associated myocarditis reported in the World Health Organization Pharmacovigilance Database. Nat. Commun. 13, 25 (2022).","journal-title":"Nat. Commun."},{"key":"1276_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05951-z","volume":"12","author":"M Fu","year":"2022","unstructured":"Fu, M. et al. Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014. Sci. Rep. 12, 1810 (2022).","journal-title":"Sci. Rep."},{"key":"1276_CR23","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s00392-024-02494-3","volume":"114","author":"FA Rottmann","year":"2025","unstructured":"Rottmann, F. A. et al. Myocarditis incidence and hospital mortality from 2007 to 2022: insights from a nationwide registry. Clin. Res. Cardiol. 114, 1156\u20131163 (2025).","journal-title":"Clin. Res. Cardiol."},{"key":"1276_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf671","volume":"10","author":"N Majunke","year":"2025","unstructured":"Majunke, N. et al. Fulminant myocarditis: outcome predictors in an international cohort study. Eur. Heart J. 10, ehaf671 (2025).","journal-title":"Eur. Heart J."},{"key":"1276_CR25","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1093\/eurheartj\/ehad707","volume":"44","author":"F Huang","year":"2023","unstructured":"Huang, F. et al. Fulminant myocarditis proven by early biopsy and outcomes. Eur. Heart J. 44, 5110\u20135124 (2023).","journal-title":"Eur. Heart J."},{"key":"1276_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jacc.2019.04.063","volume":"74","author":"E Ammirati","year":"2019","unstructured":"Ammirati, E. et al. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 74, 299\u2013311 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR27","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.121.058869","volume":"146","author":"K Kanaoka","year":"2022","unstructured":"Kanaoka, K. et al. Features and outcomes of histologically proven myocarditis with fulminant presentation. Circulation 146, 1425\u20131433 (2022).","journal-title":"Circulation"},{"key":"1276_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023719","volume":"11","author":"T Kondo","year":"2022","unstructured":"Kondo, T. et al. Differences in prognosis and cardiac function according to required percutaneous mechanical circulatory support and histological findings in patients with fulminant myocarditis: insights from the CHANGE PUMP 2 study. J. Am. Heart Assoc. 11, e023719 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"1276_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.117.026386","volume":"136","author":"E Ammirati","year":"2017","unstructured":"Ammirati, E. et al. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation 136, 529\u2013545 (2017).","journal-title":"Circulation"},{"key":"1276_CR30","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00246-017-1638-1","volume":"38","author":"RJ Butts","year":"2017","unstructured":"Butts, R. J. et al. Characteristics of clinically diagnosed pediatric myocarditis in a contemporary multi-center cohort. Pediat. Cardiol. 38, 1175\u20131182 (2017).","journal-title":"Pediat. Cardiol."},{"key":"1276_CR31","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/biomedicines12081909","volume":"12","author":"L Pelzl","year":"2024","unstructured":"Pelzl, L. et al. Lymphocytic myocarditis in children with parvovirus B19 infection: pathological and molecular insights. Biomedicines 12, 1909 (2024).","journal-title":"Biomedicines"},{"key":"1276_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/eci.70102","volume":"55","author":"G Veronese","year":"2025","unstructured":"Veronese, G. et al. Parvovirus B19-associated myocarditis in children: a systematic review of clinical features, management and outcomes. Eur. J. Clin. Invest. 55, e70102 (2025).","journal-title":"Eur. J. Clin. Invest."},{"key":"1276_CR33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.cardfail.2023.04.010","volume":"30","author":"DM Peng","year":"2024","unstructured":"Peng, D. M. et al. Contemporary care and outcomes of critically-ill children with clinically diagnosed myocarditis. J. Card. Fail. 30, 350\u2013358 (2024).","journal-title":"J. Card. Fail."},{"key":"1276_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jacc.2023.11.019","volume":"83","author":"K Puri","year":"2024","unstructured":"Puri, K. et al. Clinical presentation, classification, and outcomes of cardiogenic shock in children. J. Am. Coll. Cardiol. 83, 595\u2013608 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR35","doi-asserted-by":"publisher","first-page":"F206","DOI":"10.1136\/adc.2009.165183","volume":"95","author":"MW Freund","year":"2010","unstructured":"Freund, M. W., Kleinveld, G., Krediet, T. G., van Loon, A. M. & Verboon-Maciolek, M. A. Prognosis for neonates with enterovirus myocarditis. Arch. Dis. Child. Fetal Neonatal Ed. 95, F206\u2013F212 (2010).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"1276_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.100857","volume":"3","author":"T Thevathasan","year":"2024","unstructured":"Thevathasan, T. et al. Sex and age characteristics in acute or chronic myocarditis: a descriptive, multicenter cohort study. JACC Adv. 3, 100857 (2024).","journal-title":"JACC Adv."},{"key":"1276_CR37","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease study 2010. Lancet 380, 2095\u20132128 (2012).","journal-title":"Lancet"},{"key":"1276_CR38","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/ejhf.3483","volume":"27","author":"L Li","year":"2025","unstructured":"Li, L. et al. The global, regional, and national burden of myocarditis in 204 countries and territories, 1990\u20132021: results from the Global Burden of Disease study 2021. Eur. J. Heart Fail. 27, 2031\u20132204 (2025).","journal-title":"Eur. J. Heart Fail."},{"key":"1276_CR39","doi-asserted-by":"publisher","first-page":"102492","DOI":"10.1016\/j.jchf.2025.03.038","volume":"13","author":"C Bouleti","year":"2025","unstructured":"Bouleti, C. et al. Contemporary epidemiology, management, and in-hospital outcomes of acute myocarditis: the prospective multicenter myocarditIRM study. JACC Heart Fail. 13, 102492 (2025).","journal-title":"JACC Heart Fail."},{"key":"1276_CR40","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2017.08.044","volume":"70","author":"GD Aquaro","year":"2017","unstructured":"Aquaro, G. D. et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study. J. Am. Coll. Cardiol. 70, 1977\u20131987 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.886607","volume":"9","author":"Y Bohbot","year":"2022","unstructured":"Bohbot, Y. et al. Clinical and cardiovascular magnetic resonance predictors of early and long-term clinical outcome in acute myocarditis. Front. Cardiovasc. Med. 9, 886607 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1276_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.118.008614","volume":"12","author":"JA White","year":"2019","unstructured":"White, J. A. et al. Natural history of myocardial injury and chamber remodeling in acute myocarditis. Circ. Cardiovasc. Imag. 12, e008614 (2019).","journal-title":"Circ. Cardiovasc. Imag."},{"key":"1276_CR43","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.amjcard.2020.02.040","volume":"125","author":"A Younis","year":"2020","unstructured":"Younis, A. et al. Sex-based differences in characteristics and in-hospital outcomes among patients with diagnosed acute myocarditis. Am. J. Cardiol. 125, 1694\u20131699 (2020).","journal-title":"Am. J. Cardiol."},{"key":"1276_CR44","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.jacc.2017.08.050","volume":"70","author":"C Gr\u00e4ni","year":"2017","unstructured":"Gr\u00e4ni, C. et al. Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J. Am. Coll. Cardiol. 70, 1964\u20131976 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR45","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jacc.2012.01.007","volume":"59","author":"S Grun","year":"2012","unstructured":"Grun, S. et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J. Am. Coll. Cardiol. 59, 1604\u20131615 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR46","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/ejhf.2496","volume":"24","author":"A Baritussio","year":"2022","unstructured":"Baritussio, A. et al. Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies. Eur. J. Heart Fail. 24, 1033\u20131044 (2022).","journal-title":"Eur. J. Heart Fail."},{"key":"1276_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2021.12.058","volume":"351","author":"C Chaligne","year":"2022","unstructured":"Chaligne, C. et al. Acute myocarditis revealing autoimmune and inflammatory disorders: clinical presentation and outcome. Int. J. Cardiol. 351, 84\u201388 (2022).","journal-title":"Int. J. Cardiol."},{"key":"1276_CR48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2020.12.052","volume":"329","author":"DS Martins","year":"2021","unstructured":"Martins, D. S. et al. Evolution of acute myocarditis in a pediatric population: an MRI based study. Int. J. Cardiol. 329, 226\u2013233 (2021).","journal-title":"Int. J. Cardiol."},{"key":"1276_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12519-022-00637-y","volume":"19","author":"SX Zhuang","year":"2023","unstructured":"Zhuang, S. X., Shi, P., Gao, H., Zhuang, Q. N. & Huang, G. Y. Clinical characteristics and mortality risk prediction model in children with acute myocarditis. World J. Pediat. 19, 180\u2013188 (2023).","journal-title":"World J. Pediat."},{"key":"1276_CR50","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","volume":"296","author":"JA Towbin","year":"2006","unstructured":"Towbin, J. A. et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296, 1867\u20131876 (2006).","journal-title":"JAMA"},{"key":"1276_CR51","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","volume":"119","author":"BJ Maron","year":"2009","unstructured":"Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M. & Mueller, F. O. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980\u20132006. Circulation 119, 1085\u20131092 (2009).","journal-title":"Circulation"},{"key":"1276_CR52","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","volume":"140","author":"SE Lipshultz","year":"2019","unstructured":"Lipshultz, S. E. et al. Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association. Circulation 140, e9\u2013e68 (2019).","journal-title":"Circulation"},{"key":"1276_CR53","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1253\/circj.CJ-16-0234","volume":"80","author":"H Matsuura","year":"2016","unstructured":"Matsuura, H. et al. Clinical features of acute and fulminant myocarditis in children \u2014 2nd nationwide survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery. Circ. J. 80, 2362\u20132368 (2016).","journal-title":"Circ. J."},{"key":"1276_CR54","doi-asserted-by":"publisher","first-page":"100332","DOI":"10.1016\/j.jhlto.2025.100332","volume":"10","author":"Z Hutchinson","year":"2025","unstructured":"Hutchinson, Z. & Law, Y. Myocarditis in children: diagnosis and management. JHLT Open 10, 100332 (2025).","journal-title":"JHLT Open"},{"key":"1276_CR55","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S2352-4642(20)30257-1","volume":"4","author":"M Dolhnikoff","year":"2020","unstructured":"Dolhnikoff, M. et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolesc. Health 4, 790\u2013794 (2020).","journal-title":"Lancet Child Adolesc. Health"},{"key":"1276_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.123.066433","volume":"150","author":"J Grune","year":"2024","unstructured":"Grune, J. et al. Virus-induced acute respiratory distress syndrome causes cardiomyopathy through eliciting inflammatory responses in the heart. Circulation 150, 49\u201361 (2024).","journal-title":"Circulation"},{"key":"1276_CR57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.15585\/mmwr.mm7310a2","volume":"73","author":"AR Yousaf","year":"2024","unstructured":"Yousaf, A. R. et al. Notes from the field: surveillance for multisystem inflammatory syndrome in children \u2014 United States, 2023. Morb. Mortal. Week. Rep. 73, 225\u2013228 (2024).","journal-title":"Morb. Mortal. Week. Rep."},{"key":"1276_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort, E. M. et al. Multisystem inflammatory syndrome in children in New York state. N. Engl. J. Med. 383, 347\u2013358 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR59","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","volume":"369","author":"J Toubiana","year":"2020","unstructured":"Toubiana, J. et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 369, m2094 (2020).","journal-title":"BMJ"},{"key":"1276_CR60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/art.40697","volume":"71","author":"N Groot","year":"2019","unstructured":"Groot, N. et al. Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 71, 290\u2013301 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1276_CR61","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1177\/0961203318804889","volume":"27","author":"JC Chang","year":"2018","unstructured":"Chang, J. C., Xiao, R., Mercer-Rosa, L., Knight, A. M. & Weiss, P. F. Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease. Lupus 27, 2146\u20132154 (2018).","journal-title":"Lupus"},{"key":"1276_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100481","volume":"22","author":"N Ouldali","year":"2022","unstructured":"Ouldali, N. et al. Development of a score for early identification of children with Kawasaki disease requiring second-line treatment in multi-ethnic populations in Europe: a multicentre retrospective cohort study. Lancet Reg. Health Eur. 22, 100481 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"1276_CR63","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.jacc.2017.09.023","volume":"70","author":"M Brambatti","year":"2017","unstructured":"Brambatti, M. et al. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J. Am. Coll. Cardiol. 70, 2363\u20132375 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR64","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1097\/INF.0000000000002844","volume":"39","author":"N Dhochak","year":"2020","unstructured":"Dhochak, N., Ram Jat, K., Sankar, J., Kabra, S. K. & Lodha, R. Hypersensitivity myocarditis due to antitubercular drugs in children. Pediat. Infect. Dis. J. 39, 1088\u20131091 (2020).","journal-title":"Pediat. Infect. Dis. J."},{"key":"1276_CR65","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","volume":"10","author":"N Hama","year":"2022","unstructured":"Hama, N., Abe, R., Gibson, A. & Phillips, E. J. Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. J. Allergy Clin. Immunol. Pract. 10, 1155\u20131167.e5 (2022).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"1276_CR66","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1192\/bjp.2024.113","volume":"225","author":"Y Kikuchi","year":"2024","unstructured":"Kikuchi, Y. et al. Effects of titration speed, gender, obesity and concomitant medications on the risk and onset time of clozapine-associated fever among Japanese patients with schizophrenia: retrospective review of charts from 21 hospitals. Br. J. Psychiatry 225, 492\u2013498 (2024).","journal-title":"Br. J. Psychiatry"},{"key":"1276_CR67","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/eurheartj\/ehae056","volume":"45","author":"A Hviid","year":"2024","unstructured":"Hviid, A. et al. Booster vaccination with SARS-CoV-2 mRNA vaccines and myocarditis in adolescents and young adults: a Nordic cohort study. Eur. Heart J. 45, 1327\u20131335 (2024).","journal-title":"Eur. Heart J."},{"key":"1276_CR68","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/CIRCRESAHA.115.306573","volume":"118","author":"G Fung","year":"2016","unstructured":"Fung, G., Luo, H., Qiu, Y., Yang, D. & McManus, B. Myocarditis. Circ. Res. 118, 496\u2013514 (2016).","journal-title":"Circ. Res."},{"key":"1276_CR69","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10741-012-9357-4","volume":"18","author":"S Pankuweit","year":"2013","unstructured":"Pankuweit, S. & Klingel, K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail. Rev. 18, 683\u2013702 (2013).","journal-title":"Heart Fail. Rev."},{"key":"1276_CR70","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/CIRCULATIONAHA.125.075943","volume":"153","author":"E Ammirati","year":"2026","unstructured":"Ammirati, E. et al. Clinical spectrum of children with parvovirus B19-associated acute myocarditis. Circulation 153, 699\u2013715 (2026).","journal-title":"Circulation"},{"key":"1276_CR71","doi-asserted-by":"publisher","unstructured":"Seidel, F. et al. Severe myocarditis increase in children associated with parvovirus B19 Infection: MYKKE registry and German surveillance data. JACC Heart Fail. https:\/\/doi.org\/10.1016\/j.jchf.2025.102854 (2025).","DOI":"10.1016\/j.jchf.2025.102854"},{"key":"1276_CR72","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMc0911362","volume":"362","author":"CT Bock","year":"2010","unstructured":"Bock, C. T., Klingel, K. & Kandolf, R. Human parvovirus B19-associated myocarditis. N. Engl. J. Med. 362, 1248\u20131249 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR73","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jchf.2015.05.003","volume":"3","author":"GS Bloomfield","year":"2015","unstructured":"Bloomfield, G. S. et al. Human immunodeficiency virus and heart failure in low- and middle-income countries. JACC Heart Fail. 3, 579\u2013590 (2015).","journal-title":"JACC Heart Fail."},{"key":"1276_CR74","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah, A. S. V. et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation 138, 1100\u20131112 (2018).","journal-title":"Circulation"},{"key":"1276_CR75","unstructured":"Global HIV programme: HIV data and statistics. World Health Organization https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics (2025)."},{"key":"1276_CR76","unstructured":"GBD 2021 HIV Collaborators. Global, regional, and national burden of HIV\/AIDS, 1990\u20132021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease study 2021. Lancet HIV 11, e807\u2013e822 (2024)."},{"key":"1276_CR77","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.jiph.2023.08.005","volume":"16","author":"M Sandeep","year":"2023","unstructured":"Sandeep, M. et al. Myocarditis manifestations in dengue cases: a systematic review and meta-analysis. J. Infect. Public Health 16, 1761\u20131768 (2023).","journal-title":"J. Infect. Public Health"},{"key":"1276_CR78","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5334\/gh.1129","volume":"17","author":"A Baqi","year":"2022","unstructured":"Baqi, A., Ur Rehman, F., Memon, P. S. & Omair, S. F. Prevalence and outcomes of myocarditis in dengue-infected patients admitted to a tertiary care hospital of low\u2013middle income country. Glob. Heart 17, 44 (2022).","journal-title":"Glob. Heart"},{"key":"1276_CR79","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s15010-020-01500-w","volume":"48","author":"M Bhatt","year":"2020","unstructured":"Bhatt, M. et al. Myocarditis in admitted patients with dengue fever. Infection 48, 899\u2013903 (2020).","journal-title":"Infection"},{"key":"1276_CR80","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrcardio.2014.40","volume":"11","author":"S Yacoub","year":"2014","unstructured":"Yacoub, S., Wertheim, H., Simmons, C. P., Screaton, G. & Wills, B. Cardiovascular manifestations of the emerging dengue pandemic. Nat. Rev. Cardiol. 11, 335\u2013345 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"1276_CR81","unstructured":"Dengue: areas with risk of dengue. US Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/dengue\/areas-with-risk\/index.html (2025)."},{"key":"1276_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-268","volume":"4","author":"KG Weerakoon","year":"2011","unstructured":"Weerakoon, K. G. et al. Histopathological diagnosis of myocarditis in a dengue outbreak in Sri Lanka, 2009. BMC Res. Notes 4, 268 (2011).","journal-title":"BMC Res. Notes"},{"key":"1276_CR83","unstructured":"Chikungunya: areas at risk for chikungunya. US Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/chikungunya\/data-maps\/index.html (2026)."},{"key":"1276_CR84","volume":"30","author":"WM de Souza","year":"2024","unstructured":"de Souza, W. M. et al. Chikungunya: a decade of burden in the Americas. Lancet Reg. Health Am. 30, 100673 (2024).","journal-title":"Lancet Reg. Health Am."},{"key":"1276_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00609-1","volume":"24","author":"P Venkatesan","year":"2024","unstructured":"Venkatesan, P. Global upsurge in dengue in 2024. Lancet Infect. Dis. 24, e620 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1276_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2025.101231","volume":"51","author":"P Cattaneo","year":"2025","unstructured":"Cattaneo, P. et al. Transmission of autochthonous Aedes-borne arboviruses and related public health challenges in Europe 2007\u20132023: a systematic review and secondary analysis. Lancet Reg. Health Eur. 51, 101231 (2025).","journal-title":"Lancet Reg. Health Eur."},{"key":"1276_CR87","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1939-1676.2006.tb00726.x","volume":"20","author":"AB Cannon","year":"2006","unstructured":"Cannon, A. B. et al. Acute encephalitis, polyarthritis, and myocarditis associated with West Nile virus infection in a dog. J. Vet. Intern. Med. 20, 1219\u20131223 (2006).","journal-title":"J. Vet. Intern. Med."},{"key":"1276_CR88","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/pathogens9010048","volume":"9","author":"AD Byas","year":"2020","unstructured":"Byas, A. D. & Ebel, G. D. Comparative pathology of West Nile virus in humans and non-human animals. Pathogens 9, 48 (2020).","journal-title":"Pathogens"},{"key":"1276_CR89","first-page":"8517728","volume":"2022","author":"K Lei","year":"2022","unstructured":"Lei, K., Ji, W., Bhaya, B. & Ahsan, C. A rare case of cardiac recovery after acute myocarditis from West Nile virus infection: a review of the current literature. Case Rep. Cardiol. 2022, 8517728 (2022).","journal-title":"Case Rep. Cardiol."},{"key":"1276_CR90","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.4269\/ajtmh.2006.75.1232","volume":"75","author":"SA Pergam","year":"2006","unstructured":"Pergam, S. A., DeLong, C. E., Echevarria, L., Scully, G. & Goade, D. E. Myocarditis in West Nile virus infection. Am. J. Trop. Med. Hyg. 75, 1232\u20131233 (2006).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1276_CR91","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2437244","volume":"14","author":"P Singh","year":"2025","unstructured":"Singh, P. et al. West Nile virus in a changing climate: epidemiology, pathology, advances in diagnosis and treatment, vaccine designing and control strategies, emerging public health challenges \u2014 a comprehensive review. Emerg. Microbes Infect. 14, 2437244 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"1276_CR92","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(02)00368-7","volume":"2","author":"GL Campbell","year":"2002","unstructured":"Campbell, G. L., Marfin, A. A., Lanciotti, R. S. & Gubler, D. J. West Nile virus. Lancet Infect. Dis. 2, 519\u2013529 (2002).","journal-title":"Lancet Infect. Dis."},{"key":"1276_CR93","unstructured":"Surveillance of West Nile virus infections in humans in Europe, weekly report. European Centre for Disease Prevention and Control https:\/\/www.ecdc.europa.eu\/en\/west-nile-fever\/surveillance-and-disease-data\/disease-data-ecdc (2025)."},{"key":"1276_CR94","doi-asserted-by":"publisher","first-page":"390.e395","DOI":"10.1016\/j.cmi.2022.12.001","volume":"29","author":"M Dumont","year":"2023","unstructured":"Dumont, M. et al. Myocarditis in monkeypox-infected patients: a case series. Clin. Microbiol. Infect. 29, 390.e395\u2013e397 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"1276_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2443","volume":"33","author":"A Reda","year":"2023","unstructured":"Reda, A. & Dhama, K. Mpox impact on different organ systems: complications, mechanisms, and management. Rev. Med. Virol. 33, e2443 (2023).","journal-title":"Rev. Med. Virol."},{"key":"1276_CR96","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0140-6736(25)00047-9","volume":"405","author":"I Brosius","year":"2025","unstructured":"Brosius, I. et al. Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study. Lancet 405, 547\u2013559 (2025).","journal-title":"Lancet"},{"key":"1276_CR97","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1093\/eurheartj\/ehaf222","volume":"46","author":"M Imazio","year":"2025","unstructured":"Imazio, M. et al. Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 46, 3328\u20133338 (2025).","journal-title":"Eur. Heart J."},{"key":"1276_CR98","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.056817","volume":"145","author":"E Ammirati","year":"2022","unstructured":"Ammirati, E. et al. Prevalence, characteristics, and outcomes of COVID-19-associated acute myocarditis. Circulation 145, 1123\u20131139 (2022).","journal-title":"Circulation"},{"key":"1276_CR99","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1093\/eurheartj\/ehaa664","volume":"41","author":"C Basso","year":"2020","unstructured":"Basso, C. et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur. Heart J. 41, 3827\u20133835 (2020).","journal-title":"Eur. Heart J."},{"key":"1276_CR100","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3390\/v13091880","volume":"13","author":"HT Ho","year":"2021","unstructured":"Ho, H. T., Peischard, S., Strutz-Seebohm, N., Klingel, K. & Seebohm, G. Myocardial damage by SARS-CoV-2: emerging mechanisms and therapies. Viruses 13, 1880 (2021).","journal-title":"Viruses"},{"key":"1276_CR101","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/cvr\/cvaa267","volume":"116","author":"D Bojkova","year":"2020","unstructured":"Bojkova, D. et al. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc. Res. 116, 2207\u20132215 (2020).","journal-title":"Cardiovasc. Res."},{"key":"1276_CR102","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacbts.2022.09.001","volume":"8","author":"BD Brumback","year":"2023","unstructured":"Brumback, B. D. et al. Human cardiac pericytes are susceptible to SARS-CoV-2 infection. JACC Basic Transl. Sci. 8, 109\u2013120 (2023).","journal-title":"JACC Basic Transl. Sci."},{"key":"1276_CR103","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12872-022-02534-8","volume":"22","author":"IO Lawal","year":"2022","unstructured":"Lawal, I. O., Kgatle, M. M., Mokoala, K., Farate, A. & Sathekge, M. M. Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2. BMC Cardiovasc. Disord. 22, 93 (2022).","journal-title":"BMC Cardiovasc. Disord."},{"key":"1276_CR104","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/jamacardio.2021.5133","volume":"7","author":"LT Weckbach","year":"2022","unstructured":"Weckbach, L. T. et al. Association of complement and MAPK activation with SARS-CoV-2-associated myocardial inflammation. JAMA Cardiol. 7, 286\u2013297 (2022).","journal-title":"JAMA Cardiol."},{"key":"1276_CR105","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.15585\/mmwr.mm7035e5","volume":"70","author":"TK Boehmer","year":"2021","unstructured":"Boehmer, T. K. et al. Association between COVID-19 and myocarditis using hospital-based administrative data \u2014 United States, March 2020\u2013 January 2021. Morb. Mortal. Week. Rep. 70, 1228\u20131232 (2021).","journal-title":"Morb. Mortal. Week. Rep."},{"key":"1276_CR106","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1503\/cmaj.201686","volume":"193","author":"W Murk","year":"2021","unstructured":"Murk, W. et al. Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study. Can. Med. Assoc. J. 193, E10\u2013E18 (2021).","journal-title":"Can. Med. Assoc. J."},{"key":"1276_CR107","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","volume":"28","author":"Y Xie","year":"2022","unstructured":"Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583\u2013590 (2022).","journal-title":"Nat. Med."},{"key":"1276_CR108","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/CIRCULATIONAHA.125.073086","volume":"152","author":"S Lee","year":"2025","unstructured":"Lee, S. et al. Burden of cardiovascular outcomes after SARS-CoV-2 infection in South Korea and Japan: a binational population-based cohort study. Circulation 152, 11\u201323 (2025).","journal-title":"Circulation"},{"key":"1276_CR109","first-page":"839","volume":"39","author":"M Zuin","year":"2023","unstructured":"Zuin, M. et al. One-year risk of myocarditis after COVID-19 infection: a systematic review and meta-analysis. Can. J. Cardiol. 39, 839\u2013844 (2023).","journal-title":"Can. J. Cardiol."},{"key":"1276_CR110","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2459\/JCM.0000000000001330","volume":"23","author":"GD Aquaro","year":"2022","unstructured":"Aquaro, G. D. et al. Incidence of acute myocarditis and pericarditis during the coronavirus disease 2019 pandemic: comparison with the prepandemic period. J. Cardiovasc. Med. 23, 447\u2013453 (2022).","journal-title":"J. Cardiovasc. Med."},{"key":"1276_CR111","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/vaccines11121742","volume":"11","author":"A Baritussio","year":"2023","unstructured":"Baritussio, A. et al. Uneventful COVID-19 infection and vaccination in a cohort of patients with prior myocarditis. Vaccines 11, 1742 (2023).","journal-title":"Vaccines"},{"key":"1276_CR112","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2459\/JCM.0000000000001693","volume":"26","author":"LI Birtolo","year":"2025","unstructured":"Birtolo, L. I. et al. Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian society of cardiology. J. Cardiovasc. Med. 26, 143\u2013152 (2025).","journal-title":"J. Cardiovasc. Med."},{"key":"1276_CR113","unstructured":"Malaria threat map. World Health Organization https:\/\/apps.who.int\/malaria\/maps\/threats\/#\/maps (2025)."},{"key":"1276_CR114","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archinternmed.2012.3310","volume":"172","author":"A Damasceno","year":"2012","unstructured":"Damasceno, A. et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch. Intern. Med. 172, 1386\u20131394 (2012).","journal-title":"Arch. Intern. Med."},{"key":"1276_CR115","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(25)00038-8","volume":"405","author":"DJ Weiss","year":"2025","unstructured":"Weiss, D. J. et al. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000\u201322: a spatial and temporal modelling study. Lancet 405, 979\u2013990 (2025).","journal-title":"Lancet"},{"key":"1276_CR116","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jinf.2021.03.028","volume":"82","author":"LP Kojom Foko","year":"2021","unstructured":"Kojom Foko, L. P., Arya, A., Sharma, A. & Singh, V. Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India. J. Infect. 82, 231\u2013246 (2021).","journal-title":"J. Infect."},{"key":"1276_CR117","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.4269\/ajtmh.20-1414","volume":"104","author":"AE Holm","year":"2021","unstructured":"Holm, A. E. et al. Prevalence of cardiovascular complications in malaria: a systematic review and meta-analysis. Am. J. Trop. Med. Hyg. 104, 1643\u20131650 (2021).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1276_CR118","volume":"30","author":"BR Nascimento","year":"2024","unstructured":"Nascimento, B. R. et al. Prevalence of clinical forms of chagas disease: a systematic review and meta-analysis \u2014 data from the RAISE study. Lancet Reg. Health Am. 30, 100681 (2024).","journal-title":"Lancet Reg. Health Am."},{"key":"1276_CR119","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.112.123612","volume":"127","author":"EC Sabino","year":"2013","unstructured":"Sabino, E. C. et al. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors. Circulation 127, 1105\u20131115 (2013).","journal-title":"Circulation"},{"key":"1276_CR120","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/CIRCHEARTFAILURE.115.002229","volume":"8","author":"MI Traina","year":"2015","unstructured":"Traina, M. I. et al. Prevalence and impact of Chagas disease among Latin American immigrants with nonischemic cardiomyopathy in Los Angeles, California. Circ. Heart Fail. 8, 938\u2013943 (2015).","journal-title":"Circ. Heart Fail."},{"key":"1276_CR121","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.121.055112","volume":"144","author":"MCP Nunes","year":"2021","unstructured":"Nunes, M. C. P. et al. Incidence and predictors of progression to Chagas cardiomyopathy: long-term follow-up of Trypanosoma cruzi-seropositive individuals. Circulation 144, 1553\u20131566 (2021).","journal-title":"Circulation"},{"key":"1276_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.681635","volume":"8","author":"CY Rincon-Acevedo","year":"2021","unstructured":"Rincon-Acevedo, C. Y. et al. Clinical and epidemiological characterization of acute Chagas disease in Casanare, Eastern Colombia, 2012\u20132020. Front. Med. 8, 681635 (2021).","journal-title":"Front. Med."},{"key":"1276_CR123","unstructured":"Lyme disease: Lyme disease case maps. US Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/lyme\/data-research\/facts-stats\/lyme-disease-case-map.html (2025)."},{"key":"1276_CR124","doi-asserted-by":"publisher","first-page":"339","DOI":"10.7326\/0003-4819-110-5-339","volume":"110","author":"HF McAlister","year":"1989","unstructured":"McAlister, H. F. et al. Lyme carditis: an important cause of reversible heart block. Ann. Intern. Med. 110, 339\u2013345 (1989).","journal-title":"Ann. Intern. Med."},{"key":"1276_CR125","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/cid\/ciu411","volume":"59","author":"JD Forrester","year":"2014","unstructured":"Forrester, J. D. & Mead, P. Third-degree heart block associated with Lyme carditis: review of published cases. Clin. Infect. Dis. 59, 996\u20131000 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"1276_CR126","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1016\/S1473-3099(17)30173-1","volume":"17","author":"G Alvarez-Hernandez","year":"2017","unstructured":"Alvarez-Hernandez, G. et al. Rocky Mountain spotted fever in Mexico: past, present, and future. Lancet Infect. Dis. 17, e189\u2013e196 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"1276_CR127","unstructured":"Rocky Mountain spotted fever: data and statistics on spotted fever rickettsiosis. US Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/rocky-mountain-spotted-fever\/data-research\/facts-stats\/index.html (2024)."},{"key":"1276_CR128","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S1473-3099(07)70261-X","volume":"7","author":"F Dantas-Torres","year":"2007","unstructured":"Dantas-Torres, F. Rocky mountain spotted fever. Lancet Infect. Dis. 7, 724\u2013732 (2007).","journal-title":"Lancet Infect. Dis."},{"key":"1276_CR129","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2408645","volume":"392","author":"C Devamani","year":"2025","unstructured":"Devamani, C. et al. Incidence of scrub typhus in rural south India. N. Engl. J. Med. 392, 1089\u20131099 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006062","volume":"11","author":"G Xu","year":"2017","unstructured":"Xu, G., Walker, D. H., Jupiter, D., Melby, P. C. & Arcari, C. M. A review of the global epidemiology of scrub typhus. PLoS Negl. Trop. Dis. 11, e0006062 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1276_CR131","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2467766","volume":"14","author":"JK Yeh","year":"2025","unstructured":"Yeh, J. K. et al. Beyond the infection: mapping the risk of cardiovascular events post-scrub typhus in a nationwide cohort study. Emerg. Microbes Infect. 14, 2467766 (2025).","journal-title":"Emerg. Microbes Infect."},{"key":"1276_CR132","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1056\/NEJMoa1603657","volume":"375","author":"T Weitzel","year":"2016","unstructured":"Weitzel, T. et al. Endemic scrub typhus in South America. N. Engl. J. Med. 375, 954\u2013961 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR133","unstructured":"Diphtheria: diphtheria surveillance and trends. US Centers for Disease Control and Prevention https:\/\/www.cdc.gov\/diphtheria\/php\/surveillance\/index.html (2025)."},{"key":"1276_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00026-4","volume":"24","author":"U Samarasekera","year":"2024","unstructured":"Samarasekera, U. Diphtheria outbreak in west Africa. Lancet Infect. Dis. 24, e87 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1276_CR135","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41572-019-0131-y","volume":"5","author":"NC Sharma","year":"2019","unstructured":"Sharma, N. C. et al. Diphtheria. Nat. Rev. Dis. Primers 5, 81 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1276_CR136","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1056\/NEJMoa2311981","volume":"392","author":"A Hoefer","year":"2025","unstructured":"Hoefer, A. et al. Corynebacterium diphtheriae outbreak in migrant populations in Europe. N. Engl. J. Med. 392, 2334\u20132345 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR137","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijcard.2017.01.099","volume":"239","author":"O Ceylan","year":"2017","unstructured":"Ceylan, O. & Sahin, D. A. Acute rheumatic fever and isolated myocarditis. Int. J. Cardiol. 239, 13 (2017).","journal-title":"Int. J. Cardiol."},{"key":"1276_CR138","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1161\/CIR.0000000000000921","volume":"142","author":"RK Kumar","year":"2020","unstructured":"Kumar, R. K. et al. Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association. Circulation 142, e337\u2013e357 (2020).","journal-title":"Circulation"},{"key":"1276_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.676694","volume":"8","author":"VEE Rosa","year":"2021","unstructured":"Rosa, V. E. E. et al. Rheumatic myocarditis: a poorly recognized etiology of left ventricular dysfunction in valvular heart disease patients. Front. Cardiovasc. Med. 8, 676694 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1276_CR140","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1056\/NEJMoa2110737","volume":"385","author":"G Witberg","year":"2021","unstructured":"Witberg, G. et al. Myocarditis after covid-19 vaccination in a large health care organization. N. Engl. J. Med. 385, 2132\u20132139 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR141","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa2109730","volume":"385","author":"D Mevorach","year":"2021","unstructured":"Mevorach, D. et al. Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel. N. Engl. J. Med. 385, 2140\u20132149 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR142","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.2021.24110","volume":"327","author":"ME Oster","year":"2022","unstructured":"Oster, M. E. et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA 327, 331\u2013340 (2022).","journal-title":"JAMA"},{"key":"1276_CR143","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","volume":"28","author":"M Patone","year":"2022","unstructured":"Patone, M. et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat. Med. 28, 410\u2013422 (2022).","journal-title":"Nat. Med."},{"key":"1276_CR144","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMc2205667","volume":"387","author":"L Thurner","year":"2022","unstructured":"Thurner, L. et al. IL-1RA antibodies in myocarditis after SARS-CoV-2 Vaccination. N. Engl. J. Med. 387, 1524\u20131527 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102524","volume":"19","author":"F Caso","year":"2020","unstructured":"Caso, F. et al. Could SARS-coronavirus-2 trigger autoimmune and\/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun. Rev. 19, 102524 (2020).","journal-title":"Autoimmun. Rev."},{"key":"1276_CR146","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s44161-025-00612-6","volume":"4","author":"H Maatz","year":"2025","unstructured":"Maatz, H. et al. The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccination. Nat. Cardiovasc. Res. 4, 330\u2013345 (2025).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1276_CR147","doi-asserted-by":"publisher","first-page":"517","DOI":"10.15585\/mmwr.mm7114e1","volume":"71","author":"JP Block","year":"2022","unstructured":"Block, J. P. et al. Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination \u2014 PCORnet, United States, January 2021\u2013January 2022. Morb. Mortal. Week Rep. 71, 517\u2013523 (2022).","journal-title":"Morb. Mortal. Week Rep."},{"key":"1276_CR148","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","volume":"144","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B., Kamat, I. & Hotez, P. J. Myocarditis with COVID-19 mRNA vaccines. Circulation 144, 471\u2013484 (2021).","journal-title":"Circulation"},{"key":"1276_CR149","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068665","volume":"375","author":"A Husby","year":"2021","unstructured":"Husby, A. et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study. BMJ 375, e068665 (2021).","journal-title":"BMJ"},{"key":"1276_CR150","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.amepre.2022.09.002","volume":"64","author":"J Gao","year":"2023","unstructured":"Gao, J. et al. A systematic review and meta-analysis of the association between SARS-CoV-2 vaccination and myocarditis or pericarditis. Am. J. Prev. Med. 64, 275\u2013284 (2023).","journal-title":"Am. J. Prev. Med."},{"key":"1276_CR151","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/jama.2021.13443","volume":"326","author":"GA Diaz","year":"2021","unstructured":"Diaz, G. A. et al. Myocarditis and pericarditis after vaccination for COVID-19. JAMA 326, 1210\u20131212 (2021).","journal-title":"JAMA"},{"key":"1276_CR152","doi-asserted-by":"publisher","first-page":"4470326","DOI":"10.1155\/2024\/4470326","volume":"2024","author":"C Costa","year":"2024","unstructured":"Costa, C. & Moniati, F. The epidemiology of COVID-19 vaccine-induced myocarditis. Adv. Med. 2024, 4470326 (2024).","journal-title":"Adv. Med."},{"key":"1276_CR153","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13293-024-00678-0","volume":"15","author":"DN Di Florio","year":"2024","unstructured":"Di Florio, D. N. et al. Sex differences in mitochondrial gene expression during viral myocarditis. Biol. Sex Differ. 15, 104 (2024).","journal-title":"Biol. Sex Differ."},{"key":"1276_CR154","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S2213-2600(22)00059-5","volume":"10","author":"RR Ling","year":"2022","unstructured":"Ling, R. R. et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. Lancet Resp. Med. 10, 679\u2013688 (2022).","journal-title":"Lancet Resp. Med."},{"key":"1276_CR155","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010315","volume":"16","author":"E Ammirati","year":"2023","unstructured":"Ammirati, E. et al. Outcome and morphofunctional changes on cardiac magnetic resonance in patients with acute myocarditis following mRNA COVID-19 vaccination. Circ. Heart Fail. 16, e010315 (2023).","journal-title":"Circ. Heart Fail."},{"key":"1276_CR156","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11886-024-02021-w","volume":"26","author":"E Ammirati","year":"2024","unstructured":"Ammirati, E. et al. Fulminant myocarditis temporally associated with COVID-19 vaccination. Curr. Cardiol. Rep. 26, 97\u201311 (2024).","journal-title":"Curr. Cardiol. Rep."},{"key":"1276_CR157","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/CIRCULATIONAHA.121.056583","volume":"145","author":"DT Truong","year":"2022","unstructured":"Truong, D. T. et al. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination. Circulation 145, 345\u2013356 (2022).","journal-title":"Circulation"},{"key":"1276_CR158","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-053427","volume":"148","author":"SS Jain","year":"2021","unstructured":"Jain, S. S. et al. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics 148, e2021053427 (2021).","journal-title":"Pediatrics"},{"key":"1276_CR159","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1056\/NEJMc2207270","volume":"387","author":"G Witberg","year":"2022","unstructured":"Witberg, G. et al. Myocarditis after BNT162b2 vaccination in Israeli adolescents. N. Engl. J. Med. 387, 1816\u20131817 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR160","doi-asserted-by":"publisher","first-page":"103037","DOI":"10.1016\/j.autrev.2022.103037","volume":"21","author":"C-Y Cheng","year":"2022","unstructured":"Cheng, C.-Y. et al. Myocarditis in systemic immune-mediated diseases: prevalence, characteristics and prognosis. a systematic review. Autoimmun. Rev. 21, 103037 (2022).","journal-title":"Autoimmun. Rev."},{"key":"1276_CR161","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","volume":"38","author":"ALP Caforio","year":"2017","unstructured":"Caforio, A. L. P. et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur. Heart J. 38, 2649\u20132662 (2017).","journal-title":"Eur. Heart J."},{"key":"1276_CR162","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond, C. et al. Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French vasculitis study group cohort. Arthritis Rheum. 65, 270\u2013281 (2013).","journal-title":"Arthritis Rheum."},{"key":"1276_CR163","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/acr.22686","volume":"68","author":"CA Durel","year":"2016","unstructured":"Durel, C. A. et al. Long-term followup of a multicenter cohort of 101 patients with eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss). Arthritis Care Res. 68, 374\u2013387 (2016).","journal-title":"Arthritis Care Res."},{"key":"1276_CR164","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/000331978503600705","volume":"36","author":"E Badui","year":"1985","unstructured":"Badui, E. et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 36, 431\u2013441 (1985).","journal-title":"Angiology"},{"key":"1276_CR165","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3899\/jrheum.160493","volume":"44","author":"G Thomas","year":"2017","unstructured":"Thomas, G. et al. Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J. Rheumatol. 44, 24\u201332 (2017).","journal-title":"J. Rheumatol."},{"key":"1276_CR166","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","volume":"43","author":"M Pieroni","year":"2014","unstructured":"Pieroni, M. et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin. Arthritis Rheum. 43, 526\u2013535 (2014).","journal-title":"Semin. Arthritis Rheum."},{"key":"1276_CR167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126707","volume":"10","author":"KA Mueller","year":"2015","unstructured":"Mueller, K. A. et al. Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy. PLoS ONE 10, e0126707 (2015).","journal-title":"PLoS ONE"},{"key":"1276_CR168","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","volume":"44","author":"J Lehtonen","year":"2023","unstructured":"Lehtonen, J., Uusitalo, V., P\u00f6yh\u00f6nen, P., M\u00e4yr\u00e4np\u00e4\u00e4, M. I. & Kupari, M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur. Heart J. 44, 1495\u20131510 (2023).","journal-title":"Eur. Heart J."},{"key":"1276_CR169","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/clc.21964","volume":"35","author":"L Zhang","year":"2012","unstructured":"Zhang, L., Wang, G. C., Ma, L. & Zu, N. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin. Cardiol. 35, 686\u2013691 (2012).","journal-title":"Clin. Cardiol."},{"key":"1276_CR170","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas, M. C. Inflammatory muscle diseases. N. Engl. J. Med. 372, 1734\u20131747 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR171","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/rheumatology\/keae029","volume":"63","author":"G Sen","year":"2024","unstructured":"Sen, G., Scully, P., Gordon, P. & Sado, D. Advances in the diagnosis of myocarditis in idiopathic inflammatory myopathies: an overview of diagnostic tests. Rheumatology 63, 1825\u20131836 (2024).","journal-title":"Rheumatology"},{"key":"1276_CR172","doi-asserted-by":"crossref","unstructured":"Multicenter Giant Cell Myocarditis Study Group Investigators (Cooper, L. T. Jr et al.) Idiopathic giant-cell myocarditis \u2014 natural history and treatment. N. Engl. J. Med. 336, 1860\u20131866 (1997).","DOI":"10.1056\/NEJM199706263362603"},{"key":"1276_CR173","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/ejhf.3220","volume":"26","author":"ALP Caforio","year":"2024","unstructured":"Caforio, A. L. P. et al. Long-term efficacy and safety of tailored immunosuppressive therapy in immune-mediated biopsy-proven myocarditis: a propensity-weighted study. Eur. J. Heart Fail. 26, 1175\u20131185 (2024).","journal-title":"Eur. J. Heart Fail."},{"key":"1276_CR174","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.amjcard.2008.07.041","volume":"102","author":"LT Cooper Jr.","year":"2008","unstructured":"Cooper, L. T. Jr. et al. Usefulness of immunosuppression for giant cell myocarditis. Am. J. Cardiol. 102, 1535\u20131539 (2008).","journal-title":"Am. J. Cardiol."},{"key":"1276_CR175","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCHEARTFAILURE.112.969261","volume":"6","author":"R Kandolin","year":"2013","unstructured":"Kandolin, R. et al. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ. Heart Fail. 6, 15\u201322 (2013).","journal-title":"Circ. Heart Fail."},{"key":"1276_CR176","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/modpathol.2016.75","volume":"29","author":"SA Wang","year":"2016","unstructured":"Wang, S. A. et al. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod. Pathol. 29, 854\u2013864 (2016).","journal-title":"Mod. Pathol."},{"key":"1276_CR177","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.iac.2007.07.001","volume":"27","author":"PU Ogbogu","year":"2007","unstructured":"Ogbogu, P. U., Rosing, D. R. & Horne, M. K. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol. Allergy Clin. North Am. 27, 457\u2013475 (2007).","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"1276_CR178","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/CIRCRESAHA.124.323816","volume":"134","author":"T Won","year":"2024","unstructured":"Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J. & \u010cih\u00e1kov\u00e1, D. Autoimmune myocarditis, old dogs and new tricks. Circ. Res. 134, 1767\u20131790 (2024).","journal-title":"Circ. Res."},{"key":"1276_CR179","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/rheumatology\/keae085","volume":"64","author":"X Liu","year":"2025","unstructured":"Liu, X. et al. Cardiac involvement in eosinophilic granulomatosis with polyangiitis: acute eosinophilic myocarditis and chronic inflammatory cardiomyopathy. Rheumatology 64, 722\u2013731 (2025).","journal-title":"Rheumatology"},{"key":"1276_CR180","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","volume":"85","author":"MH Drazner","year":"2025","unstructured":"Drazner, M. H. et al. 2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis. J. Am. Coll. Cardiol. 85, 391\u2013431 (2025).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR181","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145186","volume":"131","author":"J Moslehi","year":"2021","unstructured":"Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L. & Kitsis, R. N. Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms. J. Clin. Invest. 131, e145186 (2021).","journal-title":"J. Clin. Invest."},{"key":"1276_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102536","volume":"70","author":"P Gougis","year":"2024","unstructured":"Gougis, P. et al. Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade \u2014 a worldwide perspective. eClinicalMedicine 70, 102536 (2024).","journal-title":"eClinicalMedicine"},{"key":"1276_CR183","unstructured":"Regulatory approval timeline of active immunotherapies. Cancer Research Institute https:\/\/www.cancerresearch.org\/regulatory-approval-timeline-of-active-immunotherapies (2025)."},{"key":"1276_CR184","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow, M. A., Sidlow, R. & Hellmann, M. D. Immune-related adverse events associated with immune checkpoint blockade. N. Engl. J. Med. 378, 158\u2013168 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR185","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.034497","volume":"140","author":"MP Bonaca","year":"2019","unstructured":"Bonaca, M. P. et al. Myocarditis in the setting of cancer therapeutics: proposed case definitions for emerging clinical syndromes in cardio-oncology. Circulation 140, 80\u201391 (2019).","journal-title":"Circulation"},{"key":"1276_CR186","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003514","volume":"9","author":"T Tadokoro","year":"2016","unstructured":"Tadokoro, T. et al. Acute lymphocytic myocarditis with anti-PD-1 antibody nivolumab. Circ. Heart Fail. 9, e003514 (2016).","journal-title":"Circ. Heart Fail."},{"key":"1276_CR187","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","volume":"375","author":"DB Johnson","year":"2016","unstructured":"Johnson, D. B. et al. Fulminant myocarditis with combination immune checkpoint blockade. N. Engl. J. Med. 375, 1749\u20131755 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR188","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","volume":"19","author":"JE Salem","year":"2018","unstructured":"Salem, J. E. et al. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol. 19, 1579\u20131589 (2018).","journal-title":"Lancet Oncol."},{"key":"1276_CR189","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1038\/s41591-023-02591-2","volume":"29","author":"C Fenioux","year":"2023","unstructured":"Fenioux, C. et al. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nat. Med. 29, 3100\u20133110 (2023).","journal-title":"Nat. Med."},{"key":"1276_CR190","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035689","volume":"14","author":"AC Lindsay","year":"2025","unstructured":"Lindsay, A. C., Walker, A. M. & Schneeweiss, S. Myocarditis in patients starting combination checkpoint inhibitor therapy: analysis of a commercial claims database. J. Am. Heart Assoc. 14, e035689 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"1276_CR191","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jaccao.2025.01.020","volume":"7","author":"YC Chen","year":"2025","unstructured":"Chen, Y. C. et al. Immune checkpoint inhibitor myocarditis and left ventricular systolic dysfunction. JACC CardioOncol. 7, 234\u2013248 (2025).","journal-title":"JACC CardioOncol."},{"key":"1276_CR192","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1200\/JCO.22.00369","volume":"40","author":"AR Naqash","year":"2022","unstructured":"Naqash, A. R. et al. Major adverse cardiac events with immune checkpoint inhibitors: a pooled analysis of trials sponsored by the National Cancer Institute\u2013Cancer Therapy Evaluation Program. J. Clin. Oncol. 40, 3439\u20133452 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1276_CR193","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","volume":"71","author":"SS Mahmood","year":"2018","unstructured":"Mahmood, S. S. et al. Myocarditis in patients treated with immune checkpoint inhibitors. J. Am. Coll. Cardiol. 71, 1755\u20131764 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR194","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijcard.2019.08.038","volume":"296","author":"G Veronese","year":"2019","unstructured":"Veronese, G. & Ammirati, E. Differences in clinical presentation and outcome between immune checkpoint inhibitor-associated myocarditis and classical acute myocarditis: same disease, distinct challenges to face. Int. J. Cardiol. 296, 124\u2013126 (2019).","journal-title":"Int. J. Cardiol."},{"key":"1276_CR195","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2021.01.050","volume":"77","author":"P Thavendiranathan","year":"2021","unstructured":"Thavendiranathan, P. et al. Myocardial T1 and T2 mapping by magnetic resonance in patients with immune checkpoint inhibitor-associated myocarditis. J. Am. Coll. Cardiol. 77, 1503\u20131516 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR196","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/CIRCULATIONAHA.123.062405","volume":"148","author":"LH Lehmann","year":"2023","unstructured":"Lehmann, L. H. et al. Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis. Circulation 148, 473\u2013486 (2023).","journal-title":"Circulation"},{"key":"1276_CR197","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/eurheartj\/ehaf315","volume":"47","author":"JR Power","year":"2026","unstructured":"Power, J. R. et al. Immune checkpoint inhibitor-associated myocarditis: a novel risk score. Eur. Heart J. 47, 1050\u20131062 (2026).","journal-title":"Eur. Heart J."},{"key":"1276_CR198","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaccao.2025.02.004","volume":"7","author":"G Bailly","year":"2025","unstructured":"Bailly, G. et al. Rechallenge after severe immune checkpoint inhibitor myocarditis: venturing into unknown. JACC CardioOncol. 7, 300\u2013304 (2025).","journal-title":"JACC CardioOncol."},{"key":"1276_CR199","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/jcdd9070216","volume":"9","author":"F Seidel","year":"2022","unstructured":"Seidel, F. et al. Pathogenic variants in cardiomyopathy disorder genes underlie pediatric myocarditis \u2014 further impact of heterozygous immune disorder gene variants? J. Cardiovasc. Dev. Dis. 9, 216 (2022).","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"1276_CR200","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.jacc.2017.01.043","volume":"69","author":"S Belkaya","year":"2017","unstructured":"Belkaya, S. et al. Autosomal recessive cardiomyopathy presenting as acute myocarditis. J. Am. Coll. Cardiol. 69, 1653\u20131665 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR201","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.121.003426","volume":"14","author":"AR Kontorovich","year":"2021","unstructured":"Kontorovich, A. R. et al. Burden of cardiomyopathic genetic variation in lethal pediatric myocarditis. Circ. Genom. Precis. Med. 14, e003426 (2021).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1276_CR202","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jchf.2022.06.013","volume":"10","author":"E Ammirati","year":"2022","unstructured":"Ammirati, E. et al. Acute myocarditis associated with desmosomal gene variants. JACC Heart Fail. 10, 714\u2013727 (2022).","journal-title":"JACC Heart Fail."},{"key":"1276_CR203","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.003250","volume":"14","author":"F Seidel","year":"2021","unstructured":"Seidel, F. et al. Pathogenic variants associated with dilated cardiomyopathy predict outcome in pediatric myocarditis. Circ. Genom. Precis. Med. 14, e003250 (2021).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1276_CR204","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.121.003408","volume":"15","author":"C Tiron","year":"2022","unstructured":"Tiron, C. et al. Prevalence of pathogenic variants in cardiomyopathy-associated genes in myocarditis. Circ. Genom. Precis. Med. 15, e003408 (2022).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1276_CR205","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1002\/ehf2.12686","volume":"7","author":"N Piriou","year":"2020","unstructured":"Piriou, N. et al. Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies. ESC Heart Fail. 7, 1520\u20131533 (2020).","journal-title":"ESC Heart Fail."},{"key":"1276_CR206","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.hrthm.2015.01.001","volume":"12","author":"JM Lopez-Ayala","year":"2015","unstructured":"Lopez-Ayala, J. M. et al. Genetics of myocarditis in arrhythmogenic right ventricular dysplasia. Heart Rhythm. 12, 766\u2013773 (2015).","journal-title":"Heart Rhythm."},{"key":"1276_CR207","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.122.003704","volume":"15","author":"M Bourfiss","year":"2022","unstructured":"Bourfiss, M. et al. Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population. Circ. Genom. Precis. Med. 15, e003704 (2022).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1276_CR208","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.jacc.2024.02.036","volume":"83","author":"E Cabrera-Romero","year":"2024","unstructured":"Cabrera-Romero, E. et al. Penetrance of dilated cardiomyopathy in genotype-positive relatives. J. Am. Coll. Cardiol. 83, 1640\u20131651 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR209","doi-asserted-by":"publisher","first-page":"131777","DOI":"10.1016\/j.ijcard.2024.131777","volume":"400","author":"PJ Scheel","year":"2024","unstructured":"Scheel, P. J. et al. Role of genetics in inflammatory cardiomyopathy. Int. J. Cardiol. 400, 131777 (2024).","journal-title":"Int. J. Cardiol."},{"key":"1276_CR210","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jchf.2024.02.012","volume":"12","author":"E Monda","year":"2024","unstructured":"Monda, E. et al. Prevalence of pathogenic variants in cardiomyopathy-associated genes in acute myocarditis: a systematic review and meta-analysis. JACC Heart Fail. 12, 1101\u20131111 (2024).","journal-title":"JACC Heart Fail."},{"key":"1276_CR211","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.jacc.2020.04.048","volume":"75","author":"J Artico","year":"2020","unstructured":"Artico, J. et al. Lymphocytic myocarditis: a genetically predisposed disease? J. Am. Coll. Cardiol. 75, 3098\u20133100 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR212","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jchf.2024.03.015","volume":"12","author":"E Ammirati","year":"2024","unstructured":"Ammirati, E., Kontorovich, A. R. & Cooper, L. T. Jr Illuminating a hidden risk: the genetic contribution to acute myocarditis. JACC Heart Fail. 12, 1112\u20131114 (2024).","journal-title":"JACC Heart Fail."},{"key":"1276_CR213","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/heartjnl-2024-324525","volume":"111","author":"VA Rossi","year":"2025","unstructured":"Rossi, V. A. et al. Coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants: a multicentre case-control study. Heart 111, 480\u2013486 (2025).","journal-title":"Heart"},{"key":"1276_CR214","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1161\/CIRCGEN.123.004099","volume":"16","author":"M Castrichini","year":"2023","unstructured":"Castrichini, M. et al. Cardiac sarcoidosis mimickers: genetic testing in undifferentiated inflammatory cardiomyopathies. Circ. Genom. Precis. Med. 16, 478\u2013479 (2023).","journal-title":"Circ. Genom. Precis. Med."},{"key":"1276_CR215","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","volume":"402","author":"S Heymans","year":"2023","unstructured":"Heymans, S., Lakdawala, N. K., Tschope, C. & Klingel, K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet 402, 998\u20131011 (2023).","journal-title":"Lancet"},{"key":"1276_CR216","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.011204","volume":"17","author":"J Boulet","year":"2024","unstructured":"Boulet, J. et al. Cardiomyopathy in first-degree relatives of patients presenting with acute myocarditis: prevalence and prognostic significance. Circ. Heart Fail. 17, e011204 (2024).","journal-title":"Circ. Heart Fail."},{"key":"1276_CR217","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015289","volume":"9","author":"W Poller","year":"2020","unstructured":"Poller, W. et al. Familial recurrent myocarditis triggered by exercise in patients with a truncating variant of the desmoplakin gene. J. Am. Heart Assoc. 9, e015289 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"1276_CR218","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/europace\/euaa343","volume":"23","author":"R Bariani","year":"2021","unstructured":"Bariani, R. et al. \u2018Hot phase\u2019 clinical presentation in arrhythmogenic cardiomyopathy. Europace 23, 907\u2013917 (2021).","journal-title":"Europace"},{"key":"1276_CR219","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jchf.2023.09.015","volume":"12","author":"A Argiro","year":"2024","unstructured":"Argiro, A. et al. Applications of gene therapy in cardiomyopathies. JACC Heart Fail. 12, 248\u2013260 (2024).","journal-title":"JACC Heart Fail."},{"key":"1276_CR220","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1056\/NEJMoa2412392","volume":"392","author":"B Greenberg","year":"2025","unstructured":"Greenberg, B. et al. Phase 1 study of AAV9.LAMP2B gene therapy in Danon disease. N. Engl. J. Med. 392, 972\u2013983 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR221","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang, J. H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal. Transduct. Target. Ther. 9, 78 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1276_CR222","doi-asserted-by":"publisher","first-page":"131617","DOI":"10.1016\/j.ijcard.2023.131617","volume":"398","author":"E Silver","year":"2024","unstructured":"Silver, E., Argiro, A., Hong, K. & Adler, E. Gene therapy vector-related myocarditis. Int. J. Cardiol. 398, 131617 (2024).","journal-title":"Int. J. Cardiol."},{"key":"1276_CR223","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0735-1097(03)00648-X","volume":"42","author":"NE Bowles","year":"2003","unstructured":"Bowles, N. E. et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 42, 466\u2013472 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR224","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1094279","volume":"14","author":"J Hordeaux","year":"2023","unstructured":"Hordeaux, J. et al. Immune transgene-dependent myocarditis in macaques after systemic administration of adeno-associated virus expressing human acid alpha-glucosidase. Front. Immunol. 14, 1094279 (2023).","journal-title":"Front. Immunol."},{"key":"1276_CR225","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug. Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1276_CR226","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMc2212912","volume":"388","author":"CG Bonnemann","year":"2023","unstructured":"Bonnemann, C. G. et al. Dystrophin immunity after gene therapy for Duchenne\u2019s muscular dystrophy. N. Engl. J. Med. 388, 2294\u20132296 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR227","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","volume":"389","author":"A Lek","year":"2023","unstructured":"Lek, A. et al. Death after high-dose rAAV9 gene therapy in a patient with Duchenne\u2019s muscular dystrophy. N. Engl. J. Med. 389, 1203\u20131210 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR228","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jamacardio.2018.2695","volume":"3","author":"ARA Abutaleb","year":"2018","unstructured":"Abutaleb, A. R. A. et al. Myocarditis in Duchenne muscular dystrophy after changing steroids. JAMA Cardiol. 3, 1006\u20131010 (2018).","journal-title":"JAMA Cardiol."},{"key":"1276_CR229","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.ijcard.2007.10.015","volume":"132","author":"S Mavrogeni","year":"2009","unstructured":"Mavrogeni, S., Papavassiliou, A. & Cokkinos, D. V. Myocarditis in a patient with Duchenne muscular dystrophy detected by cardiovascular magnetic resonance and cardiac biopsy. Int. J. Cardiol. 132, e123\u2013e124 (2009).","journal-title":"Int. J. Cardiol."},{"key":"1276_CR230","unstructured":"Global cancer data by country. World Cancer Research Fund https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/global-cancer-data-by-country\/ (2026)."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01276-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01276-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01276-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:05:42Z","timestamp":1791921942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-026-01276-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":230,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1276"],"URL":"https:\/\/doi.org\/10.1038\/s41569-026-01276-w","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"9 March 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.K. declares speaker honoraria from Alnylam and Pfizer. C.T. has received speaker honoraria and\/or support for congress participation from AstraZeneca, Bayer, Novartis and Pfizer, and serves on the steering committee of the ARCHER trial (Cardiol Therapeutics). B.N.W. declares speaker honoraria, consulting and or Scientific Advisory Board membership for BMS, Kiniksa, Novo Nordisk and Oruka. L.T.C. is a consultant for BMS CardiolRx and Moderna, and a board member for Stromal Therapeutics. E.A. has received consultation fees from Hotgen Health Inc and Lexeo. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}